Haas A, Walzl M, Faulborn J, Walzl B, Berglöff J, Eckhardt M
Universitäts-Augenklinik, Graz.
Ophthalmologe. 1994 Jun;91(3):283-7.
Heparin-induced extracorporeal LDL precipitation (HELP) eliminates selectively fibrinogen, LDL cholesterol, cholesterol, triglycerides and LP(a) from the blood plasma using extracorporeal circulation. The reduction of fibrinogen and LDL about 50% after only one procedure immediately improves the hemorrheological situation, which has so far not been achieved by any hemorrheologically active substance. Five patients (1 central retinal vein occlusion, 3 branch vein occlusions, 1 central arterial occlusion) ranging from 59-76 years underwent HELP treatment six times over a 5-week period. After the first HELP procedure the fibrinogen was lowered from 278 +/- 57.8 to 157 +/- 22.2 mg/dl and LDL from 162.2 +/- 58 to 82.4 +/- 32.5 mg/dl. Plasma viscosity decreased from 1.3 +/- 0.07 to 1.1 +/- 0.05 mPa/s. At the end of the treatment an increase in visual acuity of 3 or more lines and an improvement in the visual field was seen in all patients. Measurements of the arteriovenous passage time with laser scan video fluorescein angiography before and at the end of the therapy showed a significant decrease from 3.5 +/- 1.59 to 2.88 +/- 1.54 s (P < 0.05) without influencing the arm-retina time. This first clinical and hemorrheological data on the HELP procedure in retinal vessel occlusion demonstrate a promising regimen in the treatment of acute retinal microcirculatory diseases.
肝素诱导的体外低密度脂蛋白沉淀(HELP)利用体外循环从血浆中选择性清除纤维蛋白原、低密度脂蛋白胆固醇、胆固醇、甘油三酯和脂蛋白(a)。仅一次治疗后,纤维蛋白原和低密度脂蛋白降低约50%,立即改善了血液流变学状况,这是迄今为止任何血液流变学活性物质都未实现的。5例年龄在59 - 76岁的患者(1例视网膜中央静脉阻塞、3例分支静脉阻塞、1例中央动脉阻塞)在5周内接受了6次HELP治疗。首次HELP治疗后,纤维蛋白原从278±57.8降至157±22.2mg/dl,低密度脂蛋白从162.2±58降至82.4±32.5mg/dl。血浆粘度从1.3±0.07降至1.1±0.05mPa/s。治疗结束时,所有患者的视力提高了3行或更多行,视野也有所改善。治疗前后用激光扫描视频荧光血管造影测量动静脉通过时间,结果显示从3.5±1.59秒显著降至2.88±1.54秒(P<0.05),且未影响臂-视网膜时间。这些关于HELP治疗视网膜血管阻塞的首批临床和血液流变学数据表明,该治疗方案在急性视网膜微循环疾病的治疗中前景广阔。